Several studies have indicated that wild-type KRAS, BRAF, PIK3CA, and phosphatase and tensin homolog (PTEN) proteins predict resistance to cetuximab as examined in a panel of CRC cell lines. This evidence concerns the gene BRAF and colorectal carcinoma.